Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-07 07:36 am Unchanged |
2023-12-31 | 13G | Pyrophyte Acquisition Corp. PHYT |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:32 am Unchanged |
2023-12-31 | 13G | Pearl Holdings Acquisition Corp PRLH |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:32 am Unchanged |
2023-12-31 | 13G | LanzaTech Global, Inc. LNZA |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:31 am Unchanged |
2023-12-31 | 13G | NKGen Biotech, Inc. Common Stock NKGN |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:30 am Unchanged |
2023-12-31 | 13G | Oxus Acquisition Corp. OXUS |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:28 am Sale |
2023-12-31 | 13G | Grosvenor Capital Management, L.P. GCMG |
ADAGE CAPITAL PARTNERS GP LLC | 2,115,777 4.920% |
-480,209 (-18.50%) |
Filing History |
| 2024-02-07 07:27 am Unchanged |
2023-12-31 | 13G | Beard Energy Transition Acquisition Corp. BRD |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:27 am Sale |
2023-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI |
ADAGE CAPITAL PARTNERS GP LLC | 29,086 1.550% |
-67,701 (-69.95%) |
Filing History |
| 2024-02-07 07:26 am Sale |
2023-12-31 | 13G | Patria Investments Limited PAX |
ADAGE CAPITAL PARTNERS GP LLC | 900,771 1.640% |
-1,896,357 (-67.80%) |
Filing History |
| 2024-02-07 07:25 am Sale |
2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
ADAGE CAPITAL PARTNERS GP LLC | 2,581,250 4.730% |
-175,000 (-6.35%) |
Filing History |
| 2024-02-07 07:25 am Unchanged |
2023-12-31 | 13G | Seaport Global Acquisition II Corp. SGII |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:24 am Sale |
2023-12-31 | 13G | Disc Medicine, Inc. IRON |
ADAGE CAPITAL PARTNERS GP LLC | 750,000 3.110% |
-412,624 (-35.49%) |
Filing History |
| 2024-02-07 07:23 am Sale |
2023-12-31 | 13G | ARYA Sciences Acquisition Corp IV ARYD |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
-1,000,000 (Position Closed) |
Filing History |
| 2024-02-07 07:23 am Sale |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
ADAGE CAPITAL PARTNERS GP LLC | 275,000 0.490% |
-2,527,627 (-90.19%) |
Filing History |
| 2024-02-07 07:21 am Unchanged |
2023-12-31 | 13G | Chenghe Acquisition Co. CHEA |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:20 am Unchanged |
2023-12-31 | 13G | Crescera Capital Acquisition Corp. CREEF |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:20 am Sale |
2023-12-31 | 13G | TORTOISEECOFIN ACQUISITION COR TRTLF |
ADAGE CAPITAL PARTNERS GP LLC | 150,000 0.860% |
-2,700,000 (-94.74%) |
Filing History |
| 2024-02-07 07:19 am Unchanged |
2023-12-31 | 13G | Acropolis Infrastructure Acquisition Corp. ACRO |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:18 am Unchanged |
2023-12-31 | 13G | Black Mountain Acquisition Corp. BMAC |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-07 07:18 am Unchanged |
2023-12-31 | 13G | PowerUp Acquisition Corp. PWUP |
ADAGE CAPITAL PARTNERS GP LLC | 0 0.000% |
0 (Unchanged) |
Filing History |